Daxor Corporation

Daxor Corporation

DXR·NASDAQ

$11.09

+7.6%
HealthcareMedical - Instruments & Supplies

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

At a Glance

Live Snapshot
Market Cap$55.86M
EPS1.8400
P/E Ratio6.03
Earnings Date08/20/2026

Available Earnings Call Transcripts

Select a year and quarter to view the full transcript.

Daxor Corporation

Daxor Corporation Earnings Call Transcripts

DXR · NASDAQ

2024

1
Q4
Mar 6
Q1
N/A
Q2
N/A
Q3
N/A

2023

1
Q4
Mar 25
Q1
N/A
Q2
N/A
Q3
N/A

2022

2
Q2
Aug 26
Q4
Mar 6
Q1
N/A
Q3
N/A